@article{05a83a85d514445199290e957ce71b51,
title = "Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder",
abstract = "Exacerbation of symptoms of obsessive-compulsive disorder (OCD) during COVID-19 or new onset of the OCD symptoms resulting from COVID-19 infection is an understudied area of research. It is possible that increased proinflammatory immune status is associated with the onset of obsessive-compulsive symptoms in patients with COVID-19 and that targeted anti-inflammatory treatments for COVID-19 infection can mitigate the new onset of Obsessive-Compulsive (OC) spectrum symptoms. In this review, we cover OCD pathogenesis as related to COVID-19, summarize the impact of cytokines on behavior, and suggest that anti-cytokine treatments can help mitigate post-COVID-19 and new onset of the OC symptoms.",
keywords = "COVID-19, Neuroinflammation, OCD, Obsessive-compulsive disorder",
author = "Vera Nezgovorova and Ferretti, {Casara Jean} and Stefano Pallanti and Eric Hollander",
note = "Funding Information: Dr. Pallanti has received funding from NIH ( R21 DA042271-01 ). Funding Information: Dr. Hollander has received research grants from GW Pharmaceuticals and Hoffman La-Roche. He has also received research funding from the Department of Defense and Food and Drug Administration Orphan Products Division. Funding Information: Dr. Hollander has received research grants from GW Pharmaceuticals and Hoffman La-Roche . He has also received research funding from the Department of Defense and Food and Drug Administration Orphan Products Division . Funding Information: Dr. Hollander has received research grants from GW Pharmaceuticals and Hoffman La-Roche. He has also received research funding from the Department of Defense and Food and Drug Administration Orphan Products Division.Dr. Pallanti has received funding from NIH (R21 DA042271-01). Publisher Copyright: {\textcopyright} 2021",
year = "2022",
month = may,
doi = "10.1016/j.jpsychires.2021.11.025",
language = "English (US)",
volume = "149",
pages = "367--373",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",
}
